Carmat

Carmat R&D per Employee

Delisted

The R&D Spending per Employee of Carmat (ALCAR.PA) as of Oct 31, 2026 is 129,953.85 EUR. In the previous year, R&D Spending per Employee was 114,792.31 EUR — a change of 13.21% (higher).

R&D per Employee

129,953.85EUR

YoY

13.21%

Last updated:

R&D Spending per Employee of Carmat is 2023 129,953.85 EUR. R&D Spending per Employee of Carmat was 2022 114,792.31 EUR. It decreases by 13.21% higher compared to the previous year.

The Carmat R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2015
80,045.50 EUR
Jan 1, 2016
109,581.70 EUR
Jan 1, 2017
131,161.78 EUR
Jan 1, 2018
209,180.04 EUR
Jan 1, 2019
225,908.94 EUR
Jan 1, 2021
145,338.46 EUR
Jan 1, 2022
114,792.31 EUR
Jan 1, 2023
129,953.85 EUR
The Carmat R&D per Employee history
YEARR&D per EmployeeYoY
129,953.85EUR+13.21%
114,792.31EUR-21.02%
145,338.46EUR-35.67%
225,908.94EUR+8.00%
209,180.04EUR+59.48%
131,161.78EUR+19.69%
109,581.70EUR+36.90%
80,045.50EUR-7.81%
86,825.93EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Carmat Stock analysis

What does Carmat do? Carmat SA is a French company that was founded in 2008 and is headquartered in Vélizy-Villacoublay, France. The company is involved in the development, manufacture, and sale of cardiovascular systems and artificial hearts. Carmat is a leader in developing technologies for the treatment of serious heart conditions and aims to provide highly innovative solutions for patients suffering from end-stage heart failure. The business model of Carmat is based on the development and commercialization of products that contribute to improving the quality of life for patients with serious heart conditions. The artificial hearts are made from biocompatible materials and can be implanted in human bodies. They can serve as a bridge to a heart transplant or even as a permanent solution for complete replacement of the natural heart. Carmat is divided into various divisions including research and development, production, sales, and marketing. The company's research and development department works on developing highly specialized technologies for the artificial hearts to enhance performance and reliability. The production department manufactures the artificial hearts and ensures a strictly controlled, sterile environment to ensure the highest quality of products. The sales and marketing team ensures that the artificial hearts are marketed and sold worldwide. Carmat currently offers the Carmat heart, which is considered a revolutionary product in the market. The heart is made from biocompatible materials and is produced through a strictly controlled process. It has been designed to maximize performance and reliability in an artificial heart solution. The artificial hearts are implanted in an elaborate and fully equipped operating room to ensure an optimal environment. Carmat has also formed partnerships with other companies and institutions to strengthen its research and development department and share knowledge and experience in the industry. This includes a partnership with Airbus, which supports the company in developing new technologies. Carmat also collaborates with medical facilities to test the artificial hearts and improve their performance. Overall, Carmat is a leading brand in the field of artificial hearts. The company aims to develop innovative products to improve the lives of people with heart failure. It has established itself as a reliable provider of artificial hearts in the market and strives to constantly improve its business activities to meet the growing demand for more effective treatment options for patients with heart problems. Carmat is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Carmat stock

R&D Spending per Employee of Carmat is 129,953.85 EUR in 2023.

R&D Spending per Employee of Carmat changed from 114,792.31 EUR to 129,953.85 EUR, representing a 13.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Carmat since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Carmat historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Carmat

All Key Metrics — Carmat